Proton therapy is a type of radiation treatment for cancer that uses protons, positively charged particles, instead of the X-rays used in conventional radiation. Its defining advantage is precision: protons can be tuned to deposit most of their energy directly inside a tumor, then stop. Standard X-ray radiation passes through the tumor and continues into healthy tissue on the other side. That difference in physics translates into less collateral damage to surrounding organs, which matters most when tumors sit near the brain, heart, spine, or eyes, or when the patient is a child whose body is still developing.
How Protons Behave Differently Than X-Rays
When an X-ray beam enters your body, it delivers radiation along its entire path, depositing dose at the skin, through the tumor, and out the other side. A proton beam behaves very differently. It delivers a relatively low dose as it enters, then releases a sharp burst of energy at a specific depth before stopping almost completely. Physicists call that energy spike the Bragg peak.
The Bragg peak exists because protons are nearly 2,000 times heavier than the electrons that carry energy in X-ray beams. That mass means protons scatter less as they travel through tissue, producing sharper edges both sideways and at the end of their range. By adjusting the energy of the beam, the treatment team can place the Bragg peak right at the tumor’s depth, then stack multiple peaks together to cover a tumor’s full thickness with a uniform dose. The result is a high, concentrated dose inside the tumor and a rapid falloff just beyond it, sparing whatever sits behind it.
Which Cancers Are Treated With Proton Therapy
Proton therapy works best for tumors that have not spread to distant parts of the body, particularly when those tumors are located in or near critical structures. The cancers most commonly treated include brain tumors, spinal tumors, head and neck cancers, lung cancer, breast cancer, esophageal cancer, prostate cancer, liver and pancreatic cancers, sarcomas, lymphoma, and nearly all pediatric cancers.
The common thread is anatomy. When a tumor wraps around the brainstem, sits just behind the heart, or grows next to a child’s developing eye or reproductive organs, every fraction of unnecessary radiation to the surrounding tissue raises the risk of lasting harm. Proton therapy’s ability to eliminate exit dose makes it especially valuable in these situations.
Why Proton Therapy Matters Most for Children
Children’s tissues are far more sensitive to radiation than adults’. A developing brain exposed to excess radiation faces a higher chance of learning and memory problems later in life. Radiation near growing bones can stunt growth. And one of the most serious long-term risks of any childhood cancer treatment is developing a second, treatment-related cancer years or decades later.
Because proton therapy reduces the volume of healthy tissue exposed to radiation, it can dramatically cut the risk of these late complications. Early studies in adults suggest the risk of developing a radiation-related cancer can be cut roughly in half with proton therapy compared to conventional radiation. For children, who have decades of life ahead in which a second cancer could appear, that reduction is even more significant. Tumors near the spine, heart, eyes, or reproductive organs are all situations where proton therapy delivers clear benefits for pediatric patients.
Organs Spared Compared to Standard Radiation
Dosimetry studies, which compare the radiation maps of proton plans versus X-ray plans on the same patients, consistently show lower doses to nearby organs with protons. In breast cancer treatment, proton therapy lowers the average dose to the heart to about 2.6 Gy compared to 5.6 Gy with intensity-modulated X-ray radiation (IMRT). For esophageal cancers, proton plans reduce exit dose to the heart and lungs. In pancreatic cancer, the kidneys, stomach, liver, and bowel all receive lower doses. For head and neck cancers, the brainstem, spinal cord, oral cavity, and salivary glands on the opposite side of the tumor are better protected.
These reductions matter in practical terms. Lower heart dose means a lower risk of heart disease years after treatment. Sparing salivary glands means less chronic dry mouth. Protecting the kidneys and liver preserves organ function that patients need for the rest of their lives. In Hodgkin lymphoma patients, pencil-beam proton therapy significantly reduced mean doses to the heart, breast tissue, lungs, spinal cord, and esophagus compared to conventional X-ray techniques.
What a Treatment Course Looks Like
Before treatment begins, you go through a planning session called simulation. The team fits you into a custom immobilization device, a mask for head and neck treatments or a body mold for tumors below the neck, designed to keep you in exactly the same position every day. You then undergo a CT scan in that position, which creates a three-dimensional model of your tumor and the surrounding anatomy. MRI or PET/CT scans are often added to define the tumor’s boundaries more precisely.
Using that 3D model, the radiation oncology team designs a plan that shapes the proton beam to match the tumor’s contour. Custom apertures and filters may be built to further sculpt the beam. At each treatment session, laser alignment systems position you to within a few millimeters of the planned location, and imaging is sometimes repeated to verify alignment before the beam turns on.
Individual sessions typically last about 30 minutes, though you should expect to be in the department for up to 90 minutes on each treatment day to account for setup, positioning, and verification. Treatment schedules vary by cancer type and can range from a handful of sessions to several weeks of daily treatments, five days a week.
How the Machines Work
Generating a beam of protons powerful enough to reach deep tumors requires a particle accelerator. Two types are used in proton therapy centers: cyclotrons and synchrotrons. Both use magnetic fields and oscillating electric fields to accelerate protons to enormous speeds.
A cyclotron accelerates protons in an expanding spiral from its center outward, extracting them at a fixed maximum energy (typically 250 million electron volts). The beam’s energy is then reduced as needed to match the tumor’s depth. A synchrotron works differently: protons are pre-accelerated in a small linear accelerator, injected into a ring, and circulated roughly 10 million times per second while an electric field boosts their energy with each pass. By varying the magnetic and electric fields in sync, a synchrotron can produce protons at whatever energy the treatment plan requires, without needing to reduce it afterward. Both approaches deliver clinically equivalent beams, and the choice between them is largely an engineering and cost decision for the facility.
Availability and Access
Proton therapy requires far more infrastructure than a standard radiation clinic. The accelerators, beam transport systems, and treatment rooms occupy dedicated buildings that cost hundreds of millions of dollars to construct. As of early 2026, roughly 147 particle therapy centers are operating worldwide, with about 50 of those in the United States. That number has grown steadily over the past decade, and new centers continue to open, but access remains limited compared to conventional radiation, which is available at thousands of facilities.
Insurance coverage varies. Many insurers cover proton therapy for cancers where clinical evidence strongly supports its use, particularly pediatric cancers, brain and spinal tumors, and head and neck cancers. For other cancer types, coverage decisions may require prior authorization and documentation that proton therapy offers a meaningful clinical advantage over standard radiation. Treatment costs are higher than conventional radiation, driven largely by the expense of building and maintaining the accelerator and treatment infrastructure. If proton therapy is recommended for you, your treatment center’s financial counselors can typically help navigate the insurance process before treatment begins.